IOL Chemicals & Pharmaceuticals Share Price

IOL Chemicals

CMP as on 20-May-22 15:58

₹ 396.40
13.95 3.65%

Open

₹ 389.00

Turnover (lac)

₹ 771

Prev. Close

₹ 382.45

Day's Vol (shares)

₹ 1,94,410

Day's Range (₹)

₹ 387.05
₹ 401.90

CMP as on20-May-22 15:29

₹ 395.00
12.5 3.27%

Open

₹ 385.25

Turnover (lac)

₹ 144

Prev. Close

₹ 382.50

Day's Vol (shares)

₹ 18,002

Day's Range

₹ 385.25
₹ 402.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 28-Jan-2022 - -
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 inter alia to consider and approve approve the Audited Financial Results of the Company for the Quarter and nine months ended 31st December 2021 and declaration of Interim Dividend if any for the Financial Year 2021-2022. Pursuant to Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 4th February 2022 has inter alia considered and approved the following: Declared an Interim Dividend of Rs. 4/- (Rupees Four Only) per Equity Share of Face Value Rs.10/- each for the Financial Year 2021-222. Fixed 16th February 2022 (Wednesday) as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive the above said Interim Dividend. The payment of the Interim Dividend shall be made to the eligible shareholders before 5th March 2022. Outcome of the Board Meeting dated 4th February 2022 and submission of Audited Financial Results for the quarter and nine months ended 31st December 2021. (As Per BSE Announcement Dated on 04.02.2022)
Board Meeting - 03-Nov-2021 - -
Quarterly Results Pursuant to Regulations 30 & 33 read with para A. 4. h of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations (Listing Regulations), we wish to inform you that the Board of Directors in its meeting held on today i.e. 12th November 2021 has inter alia considered and approved the Audited Financial Results for the Quarter and half year ended 30th September 2021. Copy of the said financial results along with unmodified Auditors Report thereon is enclosed herewith. We hereby confirm and declare that Auditors Report issued by the Statutory Auditors on the financial results of the Company for the quarter and half year ended 30th September 2021 is an Unmodified Report. The meeting of Board of Directors commenced at 03:30 PM and concluded at 5:25 PM. The above Audited Financial Results are also available on the website of the Company i.e. www.iolcp.com. This is for your information & record. Pursuant to Regulations 30 & 33 read with para A. 4. h of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations (Listing Regulations), we wish to inform you that the Board of Directors in its meeting held on today i.e. 12th November 2021 has inter alia considered and approved the Audited Financial Results for the Quarter and half year ended 30th September 2021. Copy of the said financial results along with unmodified Auditors Report thereon is enclosed herewith. We hereby confirm and declare that Auditors Report issued by the Statutory Auditors on the financial results of the Company for the quarter and half year ended 30th September 2021 is an Unmodified Report. The meeting of Board of Directors commenced at 03:30 PM and concluded at 5:25 PM. The above Audited Financial Results are also available on the website of the Company i.e. www.iolcp.com. This is for your information & record. (As per BSE Announcement Dated on 12/11/2021)
Board Meeting - 06-Aug-2021 - -
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 inter alia to consider and approve the Audited Financial Results of the Company for the Quarter ended 30th June 2021. Outcome of the Board Meeting dated 13th August 2021 and submission of Audited Financial Results for the quarter ended 30th June 2021. (As per BSE Announcement Dated on 13/8/2021)
Board Meeting - 26-May-2021 - -
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2021 ,inter alia, to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the next meeting of the Board of Directors is scheduled to be held on Friday, the 04th June 2021 inter-alia to consider and approve the Audited Financial Results of the Company for the Quarter and year ended 31st March 2021. Further, pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Companys Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons, the Trading Window which is closed with effect from 01st April 2021 shall continue to close till the expiry of 48 hours from the date of financial results for Quarter and year ended 31st March 2021 are made public. Accordingly, the trading window shall reopen on 07th June 2021. This is for your information and record. Board to consider Final Dividend- In continuation to our Notice of the Board Meeting dated 26th May 2021 wherein we have intimated for the next meeting of the Board of Directors to be held on Friday, the 04th June 2021 inter-alia to consider and approve the Audited Financial Results of the Company for the Quarter and year ended 31st March 2021. This is further to inform you that in the same Board Meeting the matter relating to the recommendation of Final Dividend for the Financial Year 2020-21 shall also be considered by the Board of Directors. (As Per BSE Announcement Dated on 31/05/2021) Pursuant to Regulations 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 4th June 2021 has recommended Final Dividend of Rs 2/- per shares (i.e. 20 % on the face value of Rs 10/- each share) for the financial year 2020-21, the same will be paid upon declaration by the shareholders in the 34th Annual General Meeting of the Company. Record date for payment of dividend shall be communicated in due course. Outcome of the Board Meeting dated 4th June 2021 and submission of Audited Financial Results for the quarter and year ended 31st March 2021 (As Per BSE Announcement Dated on 04.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity